Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

The decreased survival of von Willebrand factor (VWF) in plasma has been implicated as a mechanism in a subset of type 1 von Willebrand disease (VWD) patients. We have previously reported that the ratio of plasma levels of VWF and its propeptide (VWFpp) can be used to identify patients with reduced...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Haberichter, Sandra L., Castaman, Giancarlo, Budde, Ulrich, Peake, Ian, Goodeve, Anne, Rodeghiero, Francesco, Federici, Augusto B., Batlle, Javier, Meyer, Dominique, Mazurier, Claudine, Goudemand, Jenny, Eikenboom, Jeroen, Schneppenheim, Reinhard, Ingerslev, Jorgen, Vorlova, Zdena, Habart, David, Holmberg, Lars, Lethagen, Stefan, Pasi, John, Hill, Frank G. H., Montgomery, Robert R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2008
Schlagworte:
Hemostasis, Thrombosis, and Vascular Biology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2384129/
https://ncbi.nlm.nih.gov/pubmed/18344424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-09-110940
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge